The theory and practical application of adjuvants
著者
書誌事項
The theory and practical application of adjuvants
J. Wiley, c1995
大学図書館所蔵 全5件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
For many years, a small group of research workers worldwide has been responsible for the development of adjuvants or immunoprotectors for use in experimental vaccines and in the routine production of antisera. Adjuvants interact with cells of the immune system and trigger a number of biological effects, some of which are desirable and some less so. There is a need to keep the latter under control, although it is doubtful if there is such a thing as an innocuous adjuvant. Studies have also included such problems as isolation, preparation, dose responses, adverse reactions and practical applications. Much of this information is spread throughout the literature over the last 25 years, and this book aims, therefore, to bring the information together through contributions from a group of internationally renowned scientists. This book deals with the well-documented adjuvant or immuno-potentiating preparations which have been developed by leading groups throughout the world. Among others these preparations include: aluminum absorbents; black copolymers; Freund's complete and incomplete adjuvants; muramyl dipeptide and its synthetic derivatives; ISCOMs; lipid A; liposomes; and saponins.
The benefits and pitfalls associated with the use of each of these different adjuvants are described which will help to prevent their misuse in laboratory studies and the potential use of adjuvants in AIDS vaccines is also covered. The book also aims to provide a source of practical hints for and uses by immunologists, microbiologists, parasitologists and vaccinologists. In addition those interested in developing new adjuvant preparations, either natural or synthetic, will find details within the book on the types of assay required to authenticate an adjuvant effect. The book may also enable regulatory bodies to assess the validity of tests for a variety of possible contraindications associated with the more reactive preparations when formulating quality control regulations.
目次
Partial table of contents: Freund-Type Mineral Oil Adjuvant Emulsions (D. Stewart-Tull). Aluminium Adjuvants (E. Lindblad). Synthetic Lipoid Compounds as Antigen-Specific Immunostimulators for Improving the Efficacy of Killed-Virus Vaccines (D. Katz, et al.). Copolymer Adjuvants and Titermax (R. Hunter, et al.). Saponins (J. Campbell). Immune Stimulating Complexes with Quil A (K. Dalsgaard, et al.). Liposomes as Immunological Adjuvants (G. Gregoriadis). Syntex Adjuvant Formulation (N. Byars & A. Allison). Muramyl Dipeptides with Special Attention to TNF (M. Parant). Lipid A (M. Nakano & M. Matsuura). Adjuvants in AIDS Vaccines (R. Bomford). Index.
「Nielsen BookData」 より